Cancer Vaccine Breakthrough - A Spark and Promising Results for Pancreatic Adenocarcinoma Patients

Friday, March 29 at 2:30 pm ET

Register to Attend Online (Free)

You'll be able to join live while we record.
You are all registered!

You will get an email with all the information you'll need to connect.

We look forward to seeing you!
Oops! Something went wrong while submitting the form.

Cancer Vaccines are Showing Promise: New data have shown very promising results for pancreatic cancer patients in a study of BioNTech's cancer vaccine.

In this webinar, we discuss what a cancer vaccine is—an immunotherapy method to treat existing cancer—and what it is not (a way to prevent cancer). We delve into how the cancer vaccine works, highlighting the use of checkpoint inhibitors and the innovative process of personalizing the vaccine for each patient based on algorithms.

We go over the findings and results, including an amazing response in 50% of the patients. This section reviews why this personalized response is significant for patients with KRAS, p53, and other genetic alterations.

Furthermore, we discuss the implications for patients now and how we at Sagely Health are working to track treatments like these and facilitate patient access.

Dr. Sager also brings to light the intriguing findings related to 'Patient 29' and what this could potentially mean for metastatic cancer patients.

‍

Got questions or need help? Request a Consultation